Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
NervGen Pharma Corp. (NGEN) had Free Cash Flow per Share of $-0.07 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.22M |
|
-- |
|
-- |
|
$5.49M |
|
$-5.49M |
|
$4.27M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-5.49M |
|
$-5.48M |
|
79.90M |
|
80.86M |
|
$-0.01 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$14.85M |
|
-- |
|
$0.29M |
|
$15.14M |
|
$11.10M |
|
-- |
|
-- |
|
$11.10M |
|
$4.04M |
|
$3.75M |
|
$4.04M |
|
80.99M |
|
| Cash Flow Statement Financials | |
$-5.98M |
|
$0.01M |
|
$2.03M |
|
$16.09M |
|
$12.07M |
|
$-4.02M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.24% |
|
-32.56% |
|
-8.07% |
|
-30.24% |
|
$0.05 |
|
|
Free Cash Flow per Share |
$-0.07 |
$-0.07 |
|